Work

IRAK1/4i is well-tolerated in mice and synergizes with gemcitabine in inducing apoptosis, suppressing proliferation and fibrosis of PDAC in vivo from Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma

Year: 2023

Type: other

Abstract: Supplementary Figure 3. IRAK1/4i is well-tolerated in mice and synergizes with gemcitabine in inducing apoptosis, suppressing proliferation and fibrosis of PDAC in vivo.

DOI: 10.1158/1078-0432.22464776

Authors: Daoxiang Zhang, Lin Li, Hongmei Jiang, Brett L. Knolhoff, Albert C. Lockhart, Andrea Wang-Gillam, David G. DeNardo, Marianna B. Ruzinova, Kian-Huat Lim

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361886009

Cites:

Cited by:

Related to: 10